Select Page

Home / Share Price Target / Gland

Gland Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts

Gland Pharma Limited

Company LogoSymbol: GLAND
Price: ₹1,749.05
Exchange: NSE
Healthcare -> Drug Manufacturers - General
Show Table of Contents

Gland Pharma Brief Company Overview

Company Overview of Gland Pharma Limited

Gland Pharma Limited, a pioneer in the pharmaceutical industry since 1978, is renowned for its expertise in manufacturing and distributing injectable formulations globally. Headquartered in Hyderabad, India, and backed by the strength of Fosun Pharma Industrial Pte. Ltd., Gland Pharma caters to a diverse range of markets, including the United States, Europe, Canada, and Australia.

Their commitment to innovation is evident in their robust research and development initiatives, focused on pharmaceutical API products, including the synthesis of complex drug molecules. Gland Pharma offers a comprehensive portfolio of products spanning various therapeutic categories, meeting the needs of patients across the globe.

Key Products and Services:

  • Injectable formulations
  • Pharmaceutical API products
  • Contract development services

Market Presence:

  • India
  • United States
  • Europe
  • Canada
  • Australia
  • New Zealand
  • International

Reputation: Gland Pharma Limited has consistently maintained a stellar reputation in the industry, recognized for its quality products, commitment to innovation, and customer-centric approach.


Advertisement

Gland Pharma Financial Performance

MetricValueDescription
Market Capital29,668.54 CroreMarket valuation of Gland Pharma's shares.
Revenue (TTM)5,857.73 CroreTotal revenue generated by Gland Pharma over the past twelve months.
Net Income (TTM)+722.11 CroreNet Profit or Loss after all the expenses over the past twelve months.
Operating Margin12.3%Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin12.32%Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+16%Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
-25.9%Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
4.26Company's total debt divided by total shareholder equity.
Total Debt372.16 CroreSum of Gland Pharma's current & long-term financial obligations.
Total Cash1,839.43 CroreTotal amount of liquid funds available to Gland Pharma.
Beta0.33Beta is less than 1 indicating that the Gland Pharma's price is less volatile than the market.

Is Gland Pharma A Good Buy For Long Term?

Gland Pharma's recent performance is a mixed bag. While it boasts a large market cap and healthy revenue, its Q1 2024-25 earnings have declined by 25.9% compared to the same period last year. The company's debt level, though not excessive, is a concern. The positive cash balance and 6.39% return over the past 12 months are encouraging, but the long-term outlook is clouded by the recent decline in returns. Overall, it's a "hold" for now, but I'd suggest keeping a close eye on future earnings reports before considering a long-term investment.

To predict the Gland Pharma's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Gland Pharma Share Price Target For 2024

 Gland Pharma Targets For 2024 Chart

The line chart displays the monthly closing prices of Gland Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Gland Pharma shares in 2024, see the table below.

Advertisement

Gland Pharma Share Price Target Table For 2024

Gland Pharma's LevelsValueReason/Importance
2024 Target 31795.00 (+2.62%)Price Action: 03 Oct 2024 High
2024 Target 21775.80 (+1.52%)Price Action: Aug 2023 High
2024 Target 11758.14 (+0.51%)Custom Fibonacci Extension Lvl 23.6%
Current Price1749.05 Gland Pharma's 1 share price as of Fri 04 Oct 2024
Stop Loss 11739.66 (-0.54%)Price Action: Chart
Stop Loss 21718.00 (-1.78%)Price Action: Oct 2023 High
Stop Loss 31690.52 (-3.35%)Fibonacci Retracement Extended 82.6%

Summary: Gland Pharma Share Price Prediction For 2024

In summary, Gland Pharma has declined by ₹-175.45, recording a notable -9.12% decrease from 1st January 2024 to 04 Oct 2024. Despite the setback, our analysis of Gland Pharma for 2024 predicts an additional rise of 0.51% to 2.62% by the end of 2024 with three potential targets T1: 1758.14, T2: 1775.80, T3: 1795.00. Stop Loss at SL1: 1739.66, SL2: 1718.00, SL3: 1690.52.

Gland Pharma has a 52-week high of ₹2220.94, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1475.05, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's share price prediction, let's now check what 2025 might hold for Gland Pharma.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Gland Pharma Share Price Target For 2025

 Gland Pharma Targets For 2025 Chart

The line chart displays the monthly closing prices of Gland Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Gland Pharma shares in 2025, see the table below.

Advertisement

Gland Pharma Share Price Target Table For 2025

Gland Pharma's LevelsValueReason/Importance
2025 Target 32258.04 (+29.1%)Price Action: Chart
2025 Target 22215.94 (+26.69%)Price Action: Chart
2025 Target 12194.00 (+25.43%)Fibonacci Extension Level 100%
Current Price1749.05 Gland Pharma's 1 share price as of Fri 04 Oct 2024
Stop Loss 11616.45 (-7.59%)Price Action: Sep 2023 Low
Stop Loss 21600.29 (-8.51%)Price Action: Chart
Stop Loss 31553.45 (-11.19%)Price Action: Dec 2022 Low

Summary: Gland Pharma Share Price Prediction For 2025

In summary, Gland Pharma has declined by ₹-175.45, recording a notable -9.12% decrease from 1st January 2024 to 04 Oct 2024. Despite the setback, our analysis of Gland Pharma for 2025 predicts an additional rise of 25.43% to 29.1% by the end of 2025 with three potential targets T1: 2194.00, T2: 2215.94, T3: 2258.04. Stop Loss at SL1: 1616.45, SL2: 1600.29, SL3: 1553.45.

Gland Pharma has a All-Time high of ₹4350.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1475.05, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Gland Pharma, we have created a specific page for that check here: Gland Pharma Share Price Target For Tomorrow & Next Week

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Gland Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039

 Gland Pharma Targets Chart 2024, 2025, 2026 to 2039

This chart presents a detailed projection of Gland Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 6.6% over the next 15 years.

For complete year by year Gland Pharma long term share price target from 2024, 2025 to 2039 check the below table.

Gland Pharma Share Price Target Table From 2024, 2025, 2026 to 2039

Year Gland Pharma TargetYoY Change %
2024₹1,749.05[Current Price]
2024₹2,013.2115.1%
2025₹2,256.912.1%
2026₹2,423.117.36%
2027₹2,465.611.75%
2028₹2,791.9313.23%
2029₹2,961.356.06%
2030₹3,228.299.01%
2031₹3,383.384.8%
2032₹3,370.96-0.37%
2033₹3,746.9711.15%
2034₹3,909.484.33%
2035₹4,199.687.42%
2036₹4,343.643.42%
2037₹4,276.32-1.56%
2038₹4,702.019.95%
2039₹4,928.244.81%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Gland Pharma Past Performance

GLAND main
Gland Pharma has been listed on NSE for more than 4 years.
  • In 2020, Gland Pharma opening price was ₹2,120
  • As of Fri 04 Oct 2024 the price stands at ₹1,749.05.
  • This represents a Compound Annual Growth Rate (CAGR) of -3.77%.
  • In 4 years, an investment of 10,000 would have become ₹8,250.23.

As we wrap up, we hope you like our study on Gland Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.

Show Methodology We Use

Methodology Behind the Prediction

The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.

We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.

For more insights into Gland Pharma Limited, explore these additional resources:-

Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. My Twitter